PT  - JOURNAL ARTICLE
AU  - Mushy, Stella E.
AU  - Shishido, Eri
AU  - Horiuchi, Shigeko
TI  - Does a postpartum “Green Star” family planning decision aid for adolescent mothers reduce decisional conflict? : A quasi-experimental study
AID  - 10.1101/2022.03.10.22272184
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.10.22272184
4099  - http://medrxiv.org/content/early/2022/03/14/2022.03.10.22272184.short
4100  - http://medrxiv.org/content/early/2022/03/14/2022.03.10.22272184.full
AB  - Aim To our knowledge, there are still no studies in Tanzania regarding decision aids on long-acting reversible contraception. We evaluated the effects of our postpartum “Green Star” family planning decision aid on decisional conflict, knowledge, satisfaction, and uptake of long-acting reversible contraception among pregnant adolescents in Tanzania.Methods We used a facility-based quasi-experimental design with control. The participants were purposively recruited and randomly assigned (intervention, n = 33; control, n = 33). The intervention received the routine family planning counseling and decision aid. The control received only the routine family planning counseling. The primary outcome was change in decisional conflict measured using the validated Decisional Conflict Scale (DCS). The secondary outcomes were knowledge, satisfaction, and contraception uptake. We hypothesized that pregnant adolescents who use the decision aid will have a lower DCS score.Results We recruited 66 pregnant adolescents; 62 completed the study. Participants in the intervention had a lower mean difference score in the DCS than participants in the control (intervention: -24.7 [SD 7.99] vs. control: -11.6 [SD 10.9], t = -5.53, p < 0.001). The mean difference score in knowledge was significantly higher in the intervention than in the control (intervention: 4.53 [SD 2.54] vs. control: 2.0 [SD 1.45], t = 4.88, p < 0.001). The mean score of satisfaction was significantly higher in the intervention than in the control (intervention: 100 [SD 0.0] vs. control: 55.8 [SD 30.7], t = 8.112, p < 0.001). Choice of contraception was significantly higher in the intervention [29 (45.3%)] than in the control [13 (20.3%)] (x2 = 17.73, p < 0.001).Conclusion The postpartum “Green Star” family planning decision aid was useful as it lowered decisional conflict, improved knowledge and satisfaction with decision making, and enhanced contraception uptake. The decision aid demonstrated positive applicability and affordability for pregnant adolescents in Tanzania.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialID:UMIN000043085Clinical Protocols https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049189 Funding StatementThis work was supported by Japan Society for the Promotion of Science (JSPS) Core-to-Core Program (2021-2024) (PI: Shigeko Horiuchi). The funding was used in the data collection, analysis, and in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Boards of St. Luke?s International University (20-A091), Muhimbili University of Health and Allied Sciences(MUHAS-REC-1-2020-076), and National Institute of Medical Research approved this study. This study was registered in the Clinical Trials Registry of University Hospital Information Network in Japan (UMIN000043085).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.